Patents by Inventor Teemu Tapani JUNTTILA

Teemu Tapani JUNTTILA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2
    Publication number: 20220017637
    Abstract: The present invention relates to Her2-targeted bispecific agonistic CD28 antigen binding molecules characterized by monovalent binding to CD28, methods for their production, pharmaceutical compositions containing these antibodies, and methods of using the same.
    Type: Application
    Filed: June 22, 2021
    Publication date: January 20, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Stephan GASSER, Thomas HOFER, Teemu Tapani JUNTTILA, Christian KLEIN, Christine KUETTEL, Jenny Tosca THOM, Pablo UMAÑA
  • HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL
    Publication number: 20210024610
    Abstract: The invention relates to Her2 targeting 4-1BB agonists, in particular 4-1BBL trimer-containing antigen binding molecules comprising at least one antigen binding domain capable of specific binding to Her2 and their use in the treatment of cancer as well as their use in combination with T-cell activating anti-CD3 bispecific antibodies.
    Type: Application
    Filed: October 9, 2020
    Publication date: January 28, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Claudia FERRARA KOLLER, Teemu Tapani JUNTTILA, Christian KLEIN, Pablo UMANA, Christina CLAUS